Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T19:49:23.283Z.
Calculation as of: 2026-10-06T19:49:23.283Z.
Quote observation: 2026-10-06T19:45:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 30661e2ab8049c45f8bd89fe5e3b6011ccda1def8f6e1910b04e1fe893bb4686
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Sol-Gel Technologies Ltd.
Market Cap
$242.09M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$246.62M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$241.95M
Price/FCF Ratio
N/A
TTM Avg
780.39
3Y Avg
474.08
5Y Avg
244.04
Market Cap
$245.65M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.92M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$236.09M
Price/FCF Ratio
5.88
TTM Avg
7.87
3Y Avg
7.87
5Y Avg
7.87
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sol-Gel Technologies Ltd. (SLGL) | $242.09M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $246.62M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.95M | N/A | 780.39 | 474.08 | 244.04 |
| Q32 Bio Inc. (QTTB)vs › | $241.27M | N/A | 8.17 | 8.17 | 8.17 |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | N/A | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $239.92M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $238.57M | 20.79 | 18.26 | 16.59 | 17.78 |
| Quantum-Si incorporated (QSI)vs › | $238.38M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.09M | 5.88 | 7.87 | 7.87 | 7.87 |
| Invivyd, Inc. (IVVD)vs › | $236.07M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
